Ashok Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ashok Kumar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ali Ammar
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
1 shared publication Ameet Kumar Jesrani
Department of Radiology Jinnah Postgraduate Medical Centre
1 shared publicationHaiwei Gu
1 shared publication- Jawaid Akbar Sial
National Institute of Cardiovascular Diseases, Karachi, Pakistan
1 shared publication - Jehangir Ali Shah
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
1 shared publication - Khadijah Jack
College of Health Solutions, Arizona State University, Phoenix, USA
1 shared publication
Latest Publications
- Open Access
- 16 July 2023
- Published by Bahria University Medical and Dental College in Journal of Bahria University Medical & Dental College
- Vol. 13 (02) , 240-243
Unusual Presentation of Hepatocellular Carcinoma with Peritoneal Carcinomatosis: Importance of Abdominal Distension as a Clinical Indicator
Hepatocellular carcinoma (HCC) is a common malignancy of the liver. It is frequently diagnosed in the male gender with a racial predilection towards Asian and African populations. In addition to distant metastasis, large tumors can result in direct extrahepatic metastasis to the peritoneum and diaphragm through rupture of exophytic tumor hepatocellular carcinoma in peritoneal cavity. We report a case of a 55-year-old male having hepatocellular carcinoma secondary to hepatitis C with peritoneal metastasis. The CT abdomen with contrast triphasic study was suggestive of alarming features of chronic liver disease with multicentric hepatoma formation predominantly in segment VIII with the localized subcapsular collection. Additionally, an extensive omental thickening and nodularity were also seen in subhepatic space. Multiple nodules were seen in right cardiophrenic angle, right lower abdomen, and rectovesical pouch. In contrast to conventional chemotherapy with sorafenib, cytoreduction surgery with hyperthermic intraperitoneal chemotherapy has been shown to dramatically improve survival in patients
- 16 July 2023
- Published by Bahria University Medical and Dental College in Journal of Bahria University Medical & Dental College
- Vol. 13 (02) , 240-243
Open AccessUnusual Presentation of Hepatocellular Carcinoma with Peritoneal Carcinomatosis: Importance of Abdominal Distension as a Clinical Indicator
Hepatocellular carcinoma (HCC) is a common malignancy of the liver. It is frequently diagnosed in the male gender with a racial predilection towards Asian and African populations. In addition to distant metastasis, large tumors can result in direct extrahepatic metastasis to the peritoneum and diaphragm through rupture of exophytic tumor hepatocellular carcinoma in peritoneal cavity. We report a case of a 55-year-old male having hepatocellular carcinoma secondary to hepatitis C with peritoneal metastasis. The CT abdomen with contrast triphasic study was suggestive of alarming features of chronic liver disease with multicentric hepatoma formation predominantly in segment VIII with the localized subcapsular collection. Additionally, an extensive omental thickening and nodularity were also seen in subhepatic space. Multiple nodules were seen in right cardiophrenic angle, right lower abdomen, and rectovesical pouch. In contrast to conventional chemotherapy with sorafenib, cytoreduction surgery with hyperthermic intraperitoneal chemotherapy has been shown to dramatically improve survival in patients
- Open Access
- 3 May 2023
- Published by Elsevier in Computer Methods and Programs in Biomedicine Update
- Vol. 3
Machine and deep learning identified metabolites and clinical features associated with gallstone disease
- 3 May 2023
- Published by Elsevier in Computer Methods and Programs in Biomedicine Update
- Vol. 3
Open AccessMachine and deep learning identified metabolites and clinical features associated with gallstone disease
- Open Access
- 1 December 2021
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 14, 495-504
CHA2DS2-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions
Objective: Promising results of CHA2DS2-VASc score have been reported for the prediction of contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI). However, data of its predictive strength in the context of primary PCI are not available. Therefore, in this study, we have assessed predictive value of CHA2DS2-VASc score for CI-AKI after primary PCI. Methods: This analytical cross-sectional study was conducted between January 2021 and June 2021 at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Inclusion criteria of the study was consecutive adult patients who had undergone primary PCI. Baseline CHA2DS2-VASc score was calculated, and either a 25% or 0.5 mg/dL increase in post-procedure serum creatinine level as compared to baseline level was categorized as CI-AKI. Results: A total of 691 patients were included, of which 82.1% (567) were male. CI-AKI after primary PCI was observed in 63 (9.1%) patients, out of which 66.7% (42) of patients had CHA2DS2-VASc score of ≥ 2. The area under the curve (AUC) for the score was 0.725 [0.662 to 0.788] with a sensitivity and specificity of 66.7% [63.1% to 70.2%] and 66.7% [53.7% to 78.1%], respectively, at a cut-off value of ≥ 2. In multivariable analysis, left ventricular ejection fraction ≤ 30% and CHA2DS2-VASc ≥ 2 were found to be independent predictors with adjusted odds ratios of 2.19 [1.06– 4.5] and 2.13 [1.13– 4.01], respectively. Conclusion: CHA2DS2-VASc score has a good predictive value for the prediction of CI-AKI after primary PCI. Criteria of CHA2DS2-VASc ≥ 2 can be used for the risk stratification of CI-AKI after primary PCI.
- 1 December 2021
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 14, 495-504
Open AccessCHA2DS2-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions
Objective: Promising results of CHA2DS2-VASc score have been reported for the prediction of contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI). However, data of its predictive strength in the context of primary PCI are not available. Therefore, in this study, we have assessed predictive value of CHA2DS2-VASc score for CI-AKI after primary PCI. Methods: This analytical cross-sectional study was conducted between January 2021 and June 2021 at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Inclusion criteria of the study was consecutive adult patients who had undergone primary PCI. Baseline CHA2DS2-VASc score was calculated, and either a 25% or 0.5 mg/dL increase in post-procedure serum creatinine level as compared to baseline level was categorized as CI-AKI. Results: A total of 691 patients were included, of which 82.1% (567) were male. CI-AKI after primary PCI was observed in 63 (9.1%) patients, out of which 66.7% (42) of patients had CHA2DS2-VASc score of ≥ 2. The area under the curve (AUC) for the score was 0.725 [0.662 to 0.788] with a sensitivity and specificity of 66.7% [63.1% to 70.2%] and 66.7% [53.7% to 78.1%], respectively, at a cut-off value of ≥ 2. In multivariable analysis, left ventricular ejection fraction ≤ 30% and CHA2DS2-VASc ≥ 2 were found to be independent predictors with adjusted odds ratios of 2.19 [1.06– 4.5] and 2.13 [1.13– 4.01], respectively. Conclusion: CHA2DS2-VASc score has a good predictive value for the prediction of CI-AKI after primary PCI. Criteria of CHA2DS2-VASc ≥ 2 can be used for the risk stratification of CI-AKI after primary PCI.